Innovation1 Biotech Inc. reported earnings results for the full year ended August 31, 2022. For the full year, the company reported net loss was USD 40.88 million compared to net income of USD 1.04 million a year ago. Basic loss per share from continuing operations was USD 2.73 compared to basic earnings per share from continuing operations of USD 5.53 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | 0.00% | -99.07% |
Jan. 17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- IVBT Stock
- News Innovation1 Biotech Inc.
- Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022